Key result
Atrial natriuretic peptide levels measured at 20-26 and 30-34 weeks gestation demonstrated limited clinical utility for predicting pregnancy induced hypertension.
Why the study?
The clinical utility of measuring atrial natriuretic peptide (ANP) in the second and early third trimesters to predict pregnancy induced hypertension (PIH) was uncertain.
Does measuring atrial natriuretic peptide (ANP) predict pregnancy induced hypertension in women in their first pregnancy?
Cohort (n=200)
No
Does measuring atrial natriuretic peptide (ANP) predict pregnancy induced hypertension in women in their first pregnancy?
Answers are grounded in this paper and cite their sources.
Measuring ANP levels in the second and early third trimesters is not clinically useful for predicting pregnancy-induced hypertension.
OBJECTIVE: To explore the clinical utility of measuring atrial natriuretic peptide (ANP) in the second and early third trimesters of pregnancy in order to predict pregnancy induced hypertension (PIH). METHODS AND MATERIALS: The study was done in a University Teaching Hospital. A prospective study of 200 women in their first pregnancy was conducted. ANP was measured at 2 gestational windows, 20-26 weeks and 30-34 weeks. This was correlated with pregnancy outcomes, in particular PIH. Student's t-test was used to compare ANP levels between women who developed PIH and those who did not. The receiver operator curve (ROC) was used to determine its clinical utility. RESULTS: ANP levels were lower at 20-26 weeks in women who subsequently developed PIH but there was no significant difference at 30-34 weeks between women who had normotensive pregnancies and those who later developed PIH. The character of the ROC would indicate that it is not useful for prediction. CONCLUSION: ANP levels in the second and early third trimesters has limited clinical utility for the prediction of PIH.
No takes yet. Share an insight, caveat, or question.
Chung et al. (1995) conducted a cohort in Pregnancy induced hypertension (n=200). Atrial natriuretic peptide (ANP) levels vs. Normotensive pregnancies was evaluated on Pregnancy induced hypertension (PIH). Atrial natriuretic peptide levels measured at 20-26 and 30-34 weeks gestation demonstrated limited clinical utility for predicting pregnancy induced hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: